Carbamazepine Tablet, Extended Release
Product Images NDC 60687-583

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 60687-583). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

200 mg Carbamazepine Er Tablet Blister (200 mg Blister)

200 mg Carbamazepine Er Tablet Blister (200 mg Blister)
Carbamazepine is a medication used to treat epilepsy and neuropathic pain. The provided text is not-readable and appears to be a mix of errors and random characters.*
FDA Label Image

200 mg Carbamazepine Er Tablets Carton (200 mg Carton)

200 mg Carbamazepine Er Tablets Carton (200 mg Carton)
This is a description of Carbamazepine Extended-Release Tablets, USP in a packaging of 30 tablets (3 x 10) with NDC 60687-583-21 and Rx Only label for the usual prescription. Each tablet contains Garbamazepine USP 200mg to be swallowed whole and never crushed or chewed. It is recommended to store between 20-25°C and protect from moisture. The accompanying Medication Guide is to be dispensed by the pharmacist to each patient, and the drug product is distributed by American Hodih Packaging in Columbus, Ohio.*
FDA Label Image

400 mg Carbamazepine Er Tablet Blister (400 mg Blister)

FDA Label Image

400 mg Carbamazepine Er Tablets Carton (400 mg Carton)

400 mg Carbamazepine Er Tablets Carton (400 mg Carton)
Carbamazepine Extended-Release Tablets are a prescription medicine with 400mg Carbamazepine USP per tablet. It is advised to be swallowed whole and never chewed or crushed. The package contains 30 tablets, with the usual dosage specified on the package insert. It is recommended to store the tablets at 20° to 25°C (68° to 77°F), and protect from moisture. This medication should be kept out of reach of children. The package should not be used if the blister is torn or broken. The drug product in this package is from NDG' 16571-682, produced by Rising Pharma Holdings, Inc. and distributed by American Health Packaging in Columbus, Ohio 43217.*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.